1. Home
  2. HRL vs PODD Comparison

HRL vs PODD Comparison

Compare HRL & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

HOLD

Current Price

$20.36

Market Cap

11.8B

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$154.73

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRL
PODD
Founded
1891
2000
Country
United States
United States
Employees
N/A
5400
Industry
Meat/Poultry/Fish
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
10.3B
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
HRL
PODD
Price
$20.36
$154.73
Analyst Decision
Buy
Buy
Analyst Count
6
21
Target Price
$26.50
$341.48
AVG Volume (30 Days)
4.1M
1.5M
Earning Date
05-28-2026
05-06-2026
Dividend Yield
5.61%
N/A
EPS Growth
N/A
N/A
EPS
0.33
1.30
Revenue
$12,106,160,000.00
$2,708,100,000.00
Revenue This Year
$2.66
$24.55
Revenue Next Year
$1.62
$19.18
P/E Ratio
$61.71
$116.99
Revenue Growth
1.55
30.73
52 Week Low
$19.72
$145.59
52 Week High
$31.43
$354.88

Technical Indicators

Market Signals
Indicator
HRL
PODD
Relative Strength Index (RSI) 42.24 36.00
Support Level $20.32 N/A
Resistance Level $24.62 $205.95
Average True Range (ATR) 0.55 8.17
MACD 0.01 0.47
Stochastic Oscillator 33.77 29.75

Price Performance

Historical Comparison
HRL
PODD

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: